Clinical Trials Browser

Blood Protein Disorders, Hematologic Diseases, Multiple Myeloma, Neoplasms, Neoplasms by Histologic Type, Paraproteinemias, Renal Insufficiency, Neoplasms, Plasma Cell

NCT02999633 2022-03-21

ISLAY

Phase 2 Terminated

14 enrolled 7 charts

LymphoidOther hematologic neoplasm

Leukemia, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma

NCT00324467 2021-07-22

LYTPET

Phase 2 Unknown

150 enrolled

Lymphoid

Lymphoma, Non-Hodgkin

NCT02532322 2021-04-08

Efficacy of Acetaminophen in Posterior Fossa Surgery

Phase 2 Withdrawn

Arnold-Chiari Malformation, Infratentorial Neoplasms

NCT00185692 2019-12-04

Allogeneic Transplantation From Related Haploidentical Donors

Phase 2 Completed

16 enrolled 8 charts

LymphoidOther hematologic neoplasm

Graft vs Host Disease, Hodgkin Disease, Leukemia, Neoplasms, Hematologic Neoplasms

NCT02839668 2019-10-29

TIVA/TCI-BC

Phase 2 Completed

120 enrolled

Breast

Breast Neoplasms

NCT03111186 2019-09-26

Ibuprofen Plus Acetaminophen Versus Oxycodone Alone After Hand Surgery

Phase 2 Completed

40 enrolled

Carpal Tunnel Syndrome, Dupuytren Contracture, Ganglion Cysts, Trigger Finger Disorder, De Quervain Disease

NCT01985126 2018-06-25

An Efficacy and Safety Study of Daratumumab in Patients With Multiple Myeloma Who Have Received at Least 3 Prior Lines of Therapy (Including a Proteasome Inhibitor [PI] and Immunomodulatory Drug [IMiD]) or Are Double Refractory to a PI and an IMiD

Phase 2 Completed

124 enrolled 18 charts

Plasma cell

Multiple Myeloma

NCT00482053 2018-05-14

Phase 2 Poor Risk DLBCL of TLI and ATG Followed by Matched Allogeneic HT as Consolidation to Autologous HCT

Phase 2 Terminated

3 enrolled 13 charts

Lymphoid

Lymphoma, Non-Hodgkin, Lymphoma, B-Cell, Lymphoma, Large B-Cell, Diffuse

NCT00186628 2017-11-28

Phase 2 Trial of Prophylactic Rituximab Therapy for Prevention of CGVHD

Phase 2 Completed

36 enrolled 12 charts

LymphoidOther hematologic neoplasm

Leukemia, Mast-Cell, Lymphoma, Mantle-Cell

NCT00899847 2017-10-20

Phase 2 Study of Autologous Followed by Nonmyeloablative Allogeneic Transplantation Using TLI & ATG

Phase 2 Completed

9 enrolled 15 charts

Plasma cell

Multiple Myeloma

NCT00490009 2017-03-30

Phase 2 Study of Bexxar in Relapsed/Refractory DLCL

Phase 2 Completed

9 enrolled 10 charts

Lymphoid

Lymphoma

NCT01474304 2016-09-29

IVAC

Phase 2 Unknown

80 enrolled

Aneurysm, Nausea, Vomiting

NCT02252926 2016-08-16

Local Anesthetic Treatment of Oral Pain in Patients With Mucositis

Phase 2 Completed

70 enrolled

Other

Mucositis

NCT00003346 2013-06-25

Combination Chemotherapy in Treating Patients With Stage III or Stage IV Melanoma

Phase 2 Completed

80 enrolled

Dermatologic

Melanoma

Clinical Trials

MK-3475-01E

MK-3475-01C

Evaluation of Broccoli Seed and Sprout Extract for Detoxification of Carcinogens in Firefighters

A Phase II Study of Axicabtagene Ciloleucel, an Anti-CD19 Chimeric Antigen Receptor (CAR) Tcell Therapy, in Combination With Radiotherapy (RT) in Relapsed/Refractory Follicular Lymphoma

ADVANCE

KETOCOL

Iber-KDd

Inotuzumab Ozogamicin for Children With MRD Positive CD22+ Lymphoblastic Leukemia

Sunitinib or Cediranib for Alveolar Soft Part Sarcoma

IZALCO

No-PAIN

MEDOR

Randomized Phase II Trial of Rituximab With Either Pentostatin or Bendamustine for Multiply Relapsed or Refractory Hairy Cell Leukemia

PECS Block vs. Multimodal Analgesia for Prevention of Persistent Postoperative Pain in Breast Surgery

A Study on Pharmacokinetics (PK), Efficacy and Safety of Subcutaneous (SC) Versus Intravenous (IV) Rituximab, in Combination With CHOP (Cyclophosphamide, Doxorubicin, Vincristine, Prednisone) in Previously Untreated Participants With CD20 Positive Diffuse Large B-Cell Lymphoma (DLBCL)

A Phase 2 Study of Isatuximab in Combination With Pomalidomide and Dexamethasone in MM Patients Who Received One Prior Line of Therapy Containing Lenalidomide and a Proteasome Inhibitor

ISLAY

LYTPET

Efficacy of Acetaminophen in Posterior Fossa Surgery

Allogeneic Transplantation From Related Haploidentical Donors

TIVA/TCI-BC

Ibuprofen Plus Acetaminophen Versus Oxycodone Alone After Hand Surgery

An Efficacy and Safety Study of Daratumumab in Patients With Multiple Myeloma Who Have Received at Least 3 Prior Lines of Therapy (Including a Proteasome Inhibitor [PI] and Immunomodulatory Drug [IMiD]) or Are Double Refractory to a PI and an IMiD

Phase 2 Poor Risk DLBCL of TLI and ATG Followed by Matched Allogeneic HT as Consolidation to Autologous HCT

Phase 2 Trial of Prophylactic Rituximab Therapy for Prevention of CGVHD

Phase 2 Study of Autologous Followed by Nonmyeloablative Allogeneic Transplantation Using TLI & ATG

Phase 2 Study of Bexxar in Relapsed/Refractory DLCL

IVAC

Local Anesthetic Treatment of Oral Pain in Patients With Mucositis

Combination Chemotherapy in Treating Patients With Stage III or Stage IV Melanoma